BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 873798)

  • 61. Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up.
    Tosti A; Piraccini BM; Cambiaghi S; Jorizzo M
    Arch Dermatol; 2001 Aug; 137(8):1027-32. PubMed ID: 11493095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low-dose excimer 308-nm laser for treatment of lichen planopilaris.
    Navarini AA; Kolios AG; Prinz-Vavricka BM; Haug S; Trüeb RM
    Arch Dermatol; 2011 Nov; 147(11):1325-6. PubMed ID: 22106124
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical and photographic assessment of lichen planopilaris treatment efficacy.
    Donati A; Assouly P; Matard B; Jouanique C; Reygagne P
    J Am Acad Dermatol; 2011 Mar; 64(3):597-8; author reply 598-9. PubMed ID: 21315955
    [No Abstract]   [Full Text] [Related]  

  • 64. The role of hydroxychloroquine in the treatment of lichen planopilaris: A retrospective case series and review.
    Nic Dhonncha E; Foley CC; Markham T
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28168851
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunofluorescence findings in lichen planopilaris: a contrasting experience.
    Smith WB; Grabski WJ; McCollough ML; Davis TL
    Arch Dermatol; 1992 Oct; 128(10):1405-6. PubMed ID: 1417036
    [No Abstract]   [Full Text] [Related]  

  • 66. Lichen planopilaris beyond scalp: a case series with dermoscopy-histopathology correlation.
    Arshdeep ; Batrani M; Kubba A; Kubba R
    Int J Dermatol; 2018 Nov; 57(11):e127-e131. PubMed ID: 30073666
    [No Abstract]   [Full Text] [Related]  

  • 67. Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris.
    Strazzulla LC; Avila L; Lo Sicco K; Shapiro J
    J Drugs Dermatol; 2017 Nov; 16(11):1140-1142. PubMed ID: 29141063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Failure of lichen planopilaris to respond to ustekinumab.
    Webster G
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632941
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid and complete resolution of lichen planopilaris in juvenile chronic arthritis treated with rituximab.
    Erras S; Mouna Z; Akhdari N; Belaabidia B; Essaadouni L
    Eur J Dermatol; 2011; 21(1):116-7. PubMed ID: 21300607
    [No Abstract]   [Full Text] [Related]  

  • 70. Use of pioglitazone in patients with lichen planopilaris.
    Baibergenova A; Walsh S
    J Cutan Med Surg; 2012; 16(2):97-100. PubMed ID: 22513061
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dermatitis herpetiformis associated with lichen planopilaris.
    Isaac M; McNeely MC
    J Am Acad Dermatol; 1995 Dec; 33(6):1050-1. PubMed ID: 7490354
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream.
    Tezuka T; Saheki M; Kusuda S; Umemoto K
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):771-2. PubMed ID: 8496423
    [No Abstract]   [Full Text] [Related]  

  • 73. Tofacitinib in the treatment of lichen planopilaris: A retrospective review.
    Plante J; Eason C; Snyder A; Elston D
    J Am Acad Dermatol; 2020 Nov; 83(5):1487-1489. PubMed ID: 32473973
    [No Abstract]   [Full Text] [Related]  

  • 74. Treatment of lichen planopilaris with Janus kinase inhibitors.
    Gonzalez Matheus GA; Khosrotehrani K
    Australas J Dermatol; 2024 Jun; 65(4):381-383. PubMed ID: 38421900
    [No Abstract]   [Full Text] [Related]  

  • 75. Lichen planopilaris following whole brain irradiation.
    Perrin AJ; Donovan JC
    Int J Dermatol; 2014 Oct; 53(10):e468-70. PubMed ID: 24898573
    [No Abstract]   [Full Text] [Related]  

  • 76. Avelumab-induced lichen planopilaris, a novel association.
    Dominguez-Santas M; Fernandez-Nieto D; Diaz-Guimaraens B; Suarez-Valle A; Jimenez-Cauhe J; Saceda-Corralo D
    Int J Dermatol; 2021 Oct; 60(10):e414-e416. PubMed ID: 33826153
    [No Abstract]   [Full Text] [Related]  

  • 77. Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab.
    Maurelli M; Colato C; Tessari G; Girolomoni G
    Dermatol Ther; 2020 Nov; 33(6):e13967. PubMed ID: 32621645
    [No Abstract]   [Full Text] [Related]  

  • 78. Baricitinib as an effective treatment for lichen planopilaris.
    Li Z; Yin M; Xu N; Dou X
    Dermatol Ther; 2022 Nov; 35(11):e15882. PubMed ID: 36181307
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacy and safety of hydroxychloroquine for the management of lichen planopilaris in a real-life setting.
    Vastarella M; Cantelli M; Nappa P; Fabbrocini G; Ocampo-Garza SS
    Ital J Dermatol Venerol; 2022 Jun; 157(3):296-297. PubMed ID: 35707870
    [No Abstract]   [Full Text] [Related]  

  • 80. Preclinical evidence that the PPARγ modulator, N-Acetyl-GED-0507-34-Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris-associated damage.
    Chéret J; Piccini I; Hardman-Smart J; Ghatak S; Alam M; Lehmann J; Jimenez F; Erdmann H; Poblet E; Botchkareva N; Paus R; Bertolini M
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):e195-e197. PubMed ID: 31774585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.